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ABSTRACT
The mechanism by which HIV-1 reverse transcriptase
(HIV-RT) discriminates between the correct and
incorrect nucleotide is not clearly understood.
Chemicallymodifiednucleotidescontaining1-amino-
naphthalene-5-sulfonate (ANS) attached to their
g-phosphate were synthesized and used to probe
nucleotide selection by this error prone polymerase.
Primer extension reactions provide direct evidence
that the polymerase is able to incorporate the
gamma-modified nucleotides. Forward mutation
assays reveal a 6-fold reduction in the mutational
frequency with the modified nucleotides, and spe-
cific base substitutions are dramatically reduced or
eliminated. Molecular modeling illustrates potential
interactions between critical residues within the
polymerase active site and the modified nucleotides.
Our data demonstrate that the fidelity of reverse
transcriptase is improved using modified nucle-
otides, and we suggest that specific modifications
to the g-phosphate may be useful in designing new
antiviral therapeutics or, more generally, as a tool
for defining the structural role that the polymerase
active site has on nucleotide selectivity.
INTRODUCTION
HIV-1, the causative agent of AIDS, has evolved a variety of
ways to defeat human host defenses (1). One of these involves
evading the immune system by inaccurately replicating its
genome. HIV-1 reverse transcriptase (HIV-RT) is the
error-prone polymerase responsible for replicating the
single-stranded RNA genome of the virus and producing a
double-stranded proviral DNA (1,2). HIV-RT’s low ﬁdelity
is attributed to its lower discrimination during polymerization
and the ease at which it extends a mispaired primer terminus
(3,4). The resulting high rate of genetic variability, coupled
with the rapid accumulation of virions, facilitates escape
from the host immune response and promotes the rapid
development of drug resistant mutants under single drug regi-
mens. The need for more potent HIV inhibitors is urgent. A
clearer understanding of the enzymatic properties governing
ﬁdelity is essential for the creation of more effective antiviral
therapies.
Analysis of crystal structures of various DNA polymerases,
including HIV-RT, reveals a common architecture resembling
a partially open right hand (5,6). Each polymerase displays its
own characteristic kinetic properties which can be used to
assess ﬁdelity. Only recently well-established concepts sur-
rounding nucleotide selection have been challenged by altern-
ate theories with data showing that selection of the correct
nucleotide is governed by more than hydrogen-bonding (7,8).
One proposed mechanism for polymerase ﬁdelity is the inher-
ent ‘geometric selection’ for the proper Watson–Crick base
pair at the enzyme’s active site (9–12). In this model a correct
nucleotide is distinguished by its ﬁt within the active site and
by any free energy differences which may be ampliﬁed by
partial water exclusion (10,13–15). Analysis of amino acid
substitutions support a strictly conﬁned active site and suggest
that polymerase ﬁdelity may be a function of the pocket’s
ﬂexibility (16). Thus, polymerases with higher ﬁdelities would
have a more rigid (i.e. less ﬂexible) pocket than those with
lower ﬁdelities.
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doi:10.1093/nar/gki779It is estimated that on average one error is introduced into
the HIV-1genome at each viral replicationcycle (17–19). This
high mutation rate ( 3.4 · 10
 5) suggests that HIV-RT’s
binding pocket may be quite ﬂexible. Others have reported
that altering amino acids in or around the nucleotide binding
pocket affects ﬁdelity (20–23). We discovered that ﬁdelity can
be manipulated by engineering a phosphate group within the
nucleotide substrate.
MATERIALS AND METHODS
Recombinant HIV-RT preparation
Individual Escherichia coli cell strains carrying pRT and
p6RT51 were grown in a 3 litre:1 litre ratio, respectively,
in PSD187 media [10 g/l Bacto Tryptone, 10 g/l yeast extract,
10 g/l glycerol, 5 g K2HPO4 and 5 ml/l of trace metals solution
(4 g MgSO4·7H2O, 0.2 g NaCl, 0.4 g FeSO4·7H2O and 0.2 g
MnSO4·4H2O per 100 ml of solution adjusted to pH 3.0 with
H2SO4)] to an OD of 1–2 at 37 C. Protein was induced by the
addition of 210 mg/ml of IPTG and grown for an additional
2–3 h at 37 C. Cell cultures were centrifuged at 5000 · g then
lysed by adding 50 ml of lysis suspension [5 mM spermidine,
0.1% Triton X-100 and 25 mM NaPO4 (pH 7.0)] to each,
vortexing, and passing lysed solution through a French press
at  11000 psi at 4 C. The solution was then centrifuged at
10000 g for 30 min at 4 C. Supernatant was decanted, ﬁltered
through Whatman Filter paper no.1, and loaded onto a pre-
equilibrated 8 ml Talon Superﬂow IMAC column (Clontech).
Fifteenadditionalcolumnvolumesofrunningbuffer1[25mM
NaPO4 and 300 mM NaCl (pH 7.0)] were loaded at a linear
velocity of 100 cm/h and the column was washed with twenty
column volumes of running buffer 1. A gradient of 15 column
volumes from 0 to 500 mM imidazole was used to elute
HIV-RT, which occurred at  100 mM imidazole. Protein
fractions were pooled and dialyzed against RT buffer [50
mM Tris, 25 mM NaCl, 1 mM EDTA and 10% glycerol
(pH 7.0)]. Further puriﬁcation consisted of isocratically run-
ning HIV-RT over a 1 ml DEAE Sepharose FF Hitrap column
(Amersham Biosciences), followed by a 1 ml SP Sepharose
FF Hitrap column (Amersham Biosciences). The protein was
pooled, dialyzed against buffer containing 50 mM Tris,
25 mM NaCl, 1 mM EDTA and 50% glycerol (pH 7.0),
and stored at  80 C.
Oligodeoxyribonucleotides
A DNA primer, (TOP) d(GGTACTAAGCGGCCGCATG),
and a DNA template, (BotC6C) d(CCCCCCCCATGCGGCC-
CTTAGTACC), were used in primer extension reactions.
The DNA primer, (50Gap) d(ACAGGATTTTCGCCTGC),
was used in DNA sequencing reactions. The oligonucleotides
d(G15) and d(C30) were used as primer-template for deter-
mining the speciﬁc activity of the enzyme. All oli-
godeoxyribonucleotides were synthesized by MWG Biotech
with high-performance liquid chromatography (HPLC)
puriﬁcation.
Primer extension reactions
Reaction conditions were according to (24) with the following
modiﬁcations. Reactions were prepared by combining 5 mlo f
Solution B [160 mM KCl, 100 mM Tris–HCl (pH 8.0), 20 mM
DTT and 12 mM MgCl2] with 5 ml of Solution A which
contains 15:1 molar excess of primer-template to enzyme.
The reactions contained 0.01 U of recombinant HIV-RT isol-
ated from E.coli (pRT and p6HRT51 plasmids, generous gifts
from S.F. LeGrice), where 1 U is equal to the incorporation of
1 nmol of [a-
32P]dGTP (PerkinElmer) into an oligo (dG15)/
(dC30) primer-template at 37 C over a 15 min period. Reac-
tions were terminated by adding 20 ml of stop solution (99%
deionized formamide,0.1%xylenecyanol,0.1%bromophenol
blue and 20 mM EDTA, pH 8.0). Samples were heated
at 96 C for 3 min, placed on ice, loaded onto a 20%
polyacrylamide-urea gel, and electrophoresed for  2ha t
50 W. Intensities of unextended primer band (Io) versus
extended primer band (I1) were quantiﬁed with a Fuji MacBas
1000 phosphorimager and version 3.0 image software.
Thin layer chromatography
Thin layer chromatography was performed to examine ANS-
dGTP incorporation by HIV-RT. Modiﬁcations to the primer
extension reaction include: (i) the amount of duplex in the
primer extension reaction was increased to 100 pmol to gen-
erate detectable amounts of ANS-pyrophosphate, a product of
the incorporation event, for UV visualization, (ii) the template
oligonucleotide, (BotC6C) d(CCCCCCCCA TGCGGCCG-
CTTAGTACC), is complementary to the primer oligo(TOP)
and has a homopolymeric overhang of seven Cs (sequence
underlined), and (iii) ANS-dGTP was used at a ﬁnal concen-
tration of 100 mM. To monitor the migration of ANS-PPi,
the ANS-dGTP was treated with phosphodiesterase 1 (PDE)
(Worthington) for 10 min at room temperature in 1· PDE1
buffer. One microliter of the 10 ml primer extension reaction
was spotted onto a PEI Cellulose F plate (Merck), and the
spottedreactionswere airdriedandplaced underfoiltoprotect
them from light. The plate was then incubated in a closed
chamber with 50 ml of running buffer (70% ethanol and
6.6 mM NaCl) for 30 min, and scanned with a Bio-Rad Gel
Documentation System under UV mode with Bio-Rad
Quantity One software (Bio-Rad Laboratories, Inc., USA).
Synthesis of (5-sulfonate)-naphthalenyl-amino-g-
phosphoramidate-b,a-diphosphate-deoxynucleotides
(g-ANS-dATP)
The four g-P-aminonaphalene-5-sulfonate dNTP compounds,
A,C,GandT,weresynthesizedusingamodiﬁedprocedurefor
the synthesis of the ANS-ATP (25). The preparation of gamma
ANS-dATP is shown in Figure 1. 1-Aminonaphthalene-5-
sulphonic acid (ANS) and 1-(3-dimethylaminopropyl)-3-
ethyl-carbodiimide hydrochloride (DEC) (Lancaster); dNTP
(Sigma), and DEAE-Sephadex ion exchange resin (A-25-120)
(Aldrich).
ANS (447 mg, 2 mmol and 40 eq.) was dissolved in 10 ml
H2O. The pH of the solution was adjusted to 5.8 using NaOH
(1 N) and insoluble materials were removed by a syringe ﬁlter,
yielding a saturated solution of sodium ANS (0.18–0.2 M).
50-triphosphate-20-deoxyadenosine disodium salt (0.05 mmol)
and DEC (2 mmol) were mixed in 4 ml H2O (12.5 mM dATP)
at 22 C. The two solutions were mixed and the reaction con-
tinued for an additional 2.5 h. The pH of the reaction was kept
at 5.7–5.8 by periodic addition of 0.1 N HCl. The reaction
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using 0.05 M triethylammonium bicarbonate buffer (TEAB,
pH  7.5). The DEAE-Sephadex anion exchange column used
for puriﬁcation was pre-equilibrated with 100 ml TEAB (pH
7.5, 1 M), 100 ml aqueous sodium bicarbonate (1 M), and
100 ml TEAB (pH 7.5 and 0.05 M). The reaction mixture was
then applied to the ion exchange column at 5 C. The column
was eluted with a linear gradient of TEAB (pH 7.5) from 0.05
to 0.9 M. The product fractions were collected at  0.7 M
buffer in a total volume of about 10 ml, and detected to
emit brilliant blue ﬂuorescence at 366 nm excitation. These
fractions were pooled, freeze dried and co-evaporated twice
with H2O/ethanol (70/30). The dried residue was dissolved in
water and lyophilized to give g-ANS modiﬁed dATP as pow-
der. UV (CH3OH) lmax 245 nm. [
31P] NMR(
1H decoupled,
600 MHz, D2O, Me3PO4 external reference, 293 K, pH 6.1) d
(p.p.m.)  12.60,  14.10 and  25.79. [
31P] NMR(dATP, Na
+,
D2O 293 K) d (p.p.m.)  11.53 (g),  13.92 (a) and (b)
 24.93. The concentrations of g-ANS modiﬁed dNTPs
were obtained from 260 nm absorption readings after multi-
plying by a fraction factor that was derived from the ratio of
the absorption at 260 nm for free 1-aminonapthalene-5-
sulfonate (ANS) versus dATP (for g-ANS-dATP the factor
is 0.72). The synthesis of g-ANS-dCTP, g-ANS-dGTP and
g-ANS-dTTP followed similar procedures. Each of the
ANS-dNTPs was resuspended in MQ H2O for use.
In vitro forward mutation assay
The forward mutation bacterial strains and phage (generous
gifts from T. Kunkel) and methodology are described (26).
Two independent 25 ml reactions for each nucleotide substrate,
dNTPs or ANS-dNTPs, were performed in the presence of
0.01 U ofrecombinant HIV-RTat37 Cfor 1h.Thenucleotide
substrates used for gap-ﬁlling were at a 500 mM concentration,
and all reactions were analyzed by agarose gel electrophoresis
(0.8% gel, 25 mA and 18 h) to conﬁrm that gap-ﬁlling syn-
thesis proceeded to completion. The X-gal substrate used for
blue/white screening was replaced with S-gal/LB agar blend,
(Sigma), which produces black (wild-type) and clear (mutant)
plaques to facilitate mutant screening. All candidate mutant
plaques were re-screened in the presence of wild-type to con-
ﬁrm their phenotype. The background mutation frequency
was determined by electroporating unﬁlled gapped-duplex
DNA and screening for mutants as described. Single-
stranded M13 DNA was puriﬁed from each mutant plaque
using an M13 ssDNA kit (Qiagen) as per manufacturer’s
instructions.
Calculation of mutational frequencies
Mutational frequencies were calculated by dividing the total
number of mutants detected for a substrate (dNTPs or
ANS-dNTPs) by the total number of plaques screened for
that substrate. This mutational frequency was then corrected
by subtracting the background mutational frequency of
2.2 · 10
 4.The corrected mutationalfrequencywas then mul-
tiplied by the percentage of mutations represented in the par-
ticular class. As an example, the mutational frequency for the
dNTPs single-base substitution class was calculated by divid-
ing the number of mutants for this class (178) by the total
number of mutants detected (211) and then multiplying by the
corrected mutational frequency for the dNTPs.
DNA sequencing
Automated DNA sequencing reactions were performed in a
10 ml volume using 50 ng of puriﬁed phage ssDNA, 2 mlo f
ABI PRISM BigDye Terminator Cycle Sequencing Ready
Reaction Kit Mix v2.0, and 1.6 pmol of primer (50Gap). The
cycling regimen was as follows: 96 C for 10 s, 50 C for 1 min
and 60 C for 4 min for a total of 30 cycles. Sequencing reac-
tions were precipitated, lyophilized and resuspended in 3 ml
loading buffer (50 mg/ml Blue Dextran, 5 parts deionized
formamide, 1 part 25 mM EDTA at pH 8.0). The samples
were heated to 96 C for 2 min and one-half of the reaction
was loaded onto a 36 cm 5.3% RapidGel-XL (US Biochem-
ical). Data were collected in 2· mode on an ABI PRISM
377 DNA Sequencer and manually edited using Sequencher
v3.0 or v3.1 (GeneCodes).
Molecular modeling
The DISCOVER and HOMOLOGY modules of the INSIGHTII
program were used for the modeling studies. The CVFF force-
ﬁeld and an implicit solvent model using a distance dependent
dielectric constant (e ¼ 4 r) were introduced for the calcula-
tions (Insight II Version 2000, Accelrys Inc.). A 12 A ˚ cutoff
was applied to truncate intermolecular interactions. Minim-
ization of the initial system was carried out for 100 steps using
the steepest descent algorithm. Since the molecular system is
very large, most of it was held rigid/ﬁxed during the minim-
izationsandmoleculardynamicssimulations.TheANS-dTTP,
two Mg
2+ and 235 residues, mostly in the ﬁnger and palm
domains of the p66 domain that are neighbors of the ANS-
dTTP, were allowed to move. After initial minimization, the
system temperature was raised to 400 K for 5 ps and then
cooled to 300 K for 5 ps. The ﬁnal structures after the simu-
lated annealing were minimized for 1000 steps using the
Figure 1. Synthesisof ANS-dATP. Chemicalattachment ofANSto the gamma-phosphatepositionof20 deoxyadenosine50 triphosphate (dATP). dCTP,dGTPand
dTTP were similarly modified. All structures were confirmed via NMR.
Nucleic Acids Research, 2005, Vol. 33, No. 15 4867conjugate gradient scheme. The partial charges for each atom
of the sulfate moiety in ANS were derived from the electro-
static potential ﬁtted charges from a PM3 quantum mechanical
geometry optimization. The net charges of the oxygen atoms
in the sulfate were very similar to the oxygen atoms in the
DNA phosphate,  0.80 and  0.85, respectively. The original
X-ray structure contains three structural defects in the
p66 domain, namely missing coordinates for residues 1–2,
218–230 and 430–440 which were repaired using the
HOMOLOGY module of the INSIGHTII program. These regions
were held rigid in the modeling studies since they exist on the
oppositesideofthedNTPandDNAbindingsitessotherepairs
are notanticipatedtohaveasigniﬁcantimpact ontheseresults.
RESULTS
HIV-RT incorporates the ANS-dNTPs
Both an extended primer and a pyrophosphate group are pro-
ducts of a nucleotide incorporation event. Thus, to determine
whether the gamma-modiﬁed nucleotides are incorporated by
HIV-RT, both the accumulation of tagged-PPi and extended
DNA strands were monitored during the course of the exten-
sion reaction. Speciﬁcally, thin layer chromatography (TLC)
was used to monitor the production of ANS-pyrophosphate
(ANS-PPi) during the incorporation reaction. TLC exploits the
chemical differences of intact ANS-dGTP and ANS-PPi via
their differential migration in solvent. The intact ANS-dGTP
migrates close to the solvent front (Figure 2A, lane 1), whereas
ANS-PPi is more slowly migrating, staying near the bottom of
the plate (Figure 2A, lane 2). Extension reaction timepoints
demonstrate that as the reaction progresses, an increase in
signal for the ANS-PPi is observed (Figure 2A, lanes 3–7)
along with an accumulation of extended products (Figure 2B,
lanes 9–13). To eliminate the possibility that production of the
ANS-PPi spot might be due to reaction conditions promoting
ANS-dGTP decomposition instead of HIV-RT incorporation,
a 60 min reaction lacking HIV-RT was spotted. As shown, the
ANS-dGTP remains intact (Figure 2A, lane 8). HIV-RT’s
ability to incorporate the ANS-dGTP against a template
containing a run of seven complementary bases was also
assessed using a gel-based primer extension assay. Primer
extension products were electrophoresed on a 20% denaturing
polyacrylamide gel where each incorporated base can be
deﬁned byits difference in mobility. Extension reactions mim-
icking those performed in the TLC analysis displayed exten-
ded products over the same time period, further conﬁrming
that nucleotides modiﬁed at their gamma-phosphate with ANS
are incorporated by HIV-RT (Figure 2B). Additionally, to
address the possibility that even a minimal amount (<1%) of
contaminating natural dNTP carried over from synthesis of
the ANS-dGTP could lead to erroneous results in a primer
extension assay, the ANS-dGTP was pre-treated with shrimp
alkaline phosphatase to eliminate any natural dNTPs. Results
from this treatment did not produce differences in the amounts
of ANS-dGTP primer extension product nor did it have any
detrimental effects on the integrity of the ANS-dGTP, data not
shown.
HIV-RT mutational frequencies using natural or
ANS-modified dNTPs
Analysis of primer extension reactions comparing natural and
ANS-modiﬁed dNTPs in the context of matched and all
possible mismatched conﬁgurations demonstrated that the
modiﬁed nucleotides are incorporated by HIV-RT and that
the presence of the ANS-tag appeared to reduce misincorpora-
tion, relative to natural nucleotides (data not shown). These
reactions also demonstrated that this apparent ﬁdelity
improvement required attachment to the gamma-phosphate
of the nucleotide. To more thoroughly investigate this result
a forward mutation assay was conducted with HIV-RT to
determine the enzyme’s ﬁdelity and preference for certain
error types using either all natural or all ANS-modiﬁed
nucleotides (4,28). Two independent gap-ﬁlling reactions
were performed with each substrate and analyzed by agarose
gel electrophoresis to ensure complete synthesis. In the assay
containing all four natural dNTPs, HIV-RT produced 169
mutantplaques outofthe11334plaquesscreened,(mutational
frequencies of 1.4 and 1.8% for screen no. 1 and no. 2,
respectively), resulting in an overall mutational frequency
AB
Figure 2. Analysis of HIV-RT’s incorporation of ANS-dGTP. (A) TLC. The mobility of ANS-dGTP (lane 1) and ANS-PPi produced by PDE treatment of ANS-
dGTP (lane 2) are used as controls to monitor migration distances. A timecourse for primer extension reactions at 0, 5, 10, 30 and 60 min, respectively (lanes 3–7).
ControlconditionstoexamineANS-dGTPstabilityinreactionconditionslackingenzyme(lane8).(B)Gelelectrophoresis.Primerextensionreactionsat0,5,10,30
and 60 min, respectively (lanes 9–13). Unextended primer is indicated at the bottom of the gel image.
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 4. Whereas the assay containing all four ANS-
dNTPs produced only 26 mutant plaques out of the 10053
plaques screened, (mutational frequencies of 0.2 and 0.5% for
screen no. 1 and no. 2, respectively), resulting in an overall
mutational frequency of 26 · 10
 4. The background mutant
frequency (2.2 · 10
 4) was subtracted from each and a com-
parison of these frequencies revealed a 6-fold reduction in
mutational frequency using the ANS-dNTPs.
The speciﬁc mutations generated by HIV-RT in the lacZ
a-complementation region with either substrate (dNTPs or
ANS-dNTPs) are illustrated (Figure 3). For both cases, the
distribution of mutations is non-random and the appearance
of hot spots (three or more independent mutations at one
location) is evident. A lower incidence of hot spots is observed
withtheANS-dNTPs,butthismayreﬂecttheoverallreduction
in mutation frequency observed using the ANS-modiﬁed nuc-
leotides (Figure 3). Comparatively, the largest reduction in
mutation frequency is at positions  35 and  36 where
there were 88 errors introduced by reverse transcriptase
usingnatural dNTPs,but onlysix errors when RT incorporated
ANS-dNTPs. Typically hot spots are found within a run of
two or more of the same template base, and result in a change
to the base identity of the 50 neighboring base of the run (29).
This is generally supported by the data for both the dNTPs and
ANS-dNTPs. The other hot spot observed with both natural
and modiﬁed nucleotides occured at position +145, a region
not contained within a homopolymeric sequence (Figure 3).
Interestingly, the dG:ANS-dATP mispair, the largest hot spot
observed for the ANS-dNTPs, lies at the center of a 12-base
perfect (18-base imperfect) palindrome.
The mutational classes found for both error spectra consist
of single-base substitutions, single-base frameshifts, and com-
plex errors (i.e. multiple mutations) (Table 1). Single-base
substitutions predominate and a 6-fold difference is observed
for these errors occurring with the dNTPs versus the ANS-
dNTPs. The dNTP substitutions that occur most frequently are
themispairs:dT:dGTP,dG:dATPanddG:dTTP(Table1).The
ANS-dNTPs mispairs of dT:ANS-dGTP and dG:ANS-dATP
are observed most frequently, and each is reduced to 10- to
3-fold relative to natural nucleotides, respectively. However,
no dG:ANS-dTTP mispairs are detected.
The preferential site of introduction of a frameshift error in
both cases is within runs of a common template base. How-
ever, no frameshift hotspots are observed for the ANS-dNTPs,
possibly because of the low number of mutants recovered.
Complex errors account for 16 of the 169 screened dNTP
mutants; the majority having at least one error within a hot
spot. Only one of the 26 ANS-dNTP mutants contains non-
adjacent, multiple mutations, and neither error is located
within a region corresponding to a hot spot.
Figure 3. Results of forward mutation assays containing either natural or gamma-modified dNTPs. The identity of the mutationis shown above (naturaldNTPs) or
below (ANS-dNTPs) the sequence of the lacZ alpha-complementation region. A filled, inverted triangle represents an insertion. An empty triangle represents a
deletion.
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HIV-RT binding pocket
A plausible starting conformation of ANS-dNTP in the dNTP
binding pocket and the function of the ANS group were
investigated using molecular modeling studies. For the
modeling study, the 3.2 A ˚ X-ray structure of HIV-RT solved
by Huang et al. was employed (PDB code: 1RTD) (30). This
structure contains a DNA template, primer, and a dTTP con-
taining two Mg
2+ ions in addition to the p66 and p51 domains
that comprise the heterodimer RT. The core region around the
dTTP is rendered in Figure 4A. Based on this ternary complex,
the ANS-dTTP structure was manually constructed using the
BUILDER module of the INSIGHTII program. The ANS moiety
was introduced to one of the three oxygen atoms of the
gamma-phosphate group (Figure 4B). While the available
room for ANS was small, it could be accommodated in a few
conformations. The three oxygen atoms in the sulfate group
were placed near residue K70 of the p66 domain. Before
introducing the ANS group to the dTTP, the solvent accessible
surface of the p66 domain was investigated to examine
the available volume and its location. The surface diagram
of the X-ray structure clearly shows that some amount of
volume exists at the end of the gamma-phosphate of the
dTTP (Figure 4C), eventually extending to the solvent. Inter-
estingly, another surface map of the initial ANS-dTTP model
(Figure 4D) shows that there is a small amount of room near
the residue K70 which seems to be perfect for introduction of
the sulfate group into the ANS structure.
In an attempt to identify possible conformations of the
manually built ANS-dTTP ternary complex, a simulated
annealing method was employed. During the simulations,
most of the structure was held ﬁxed except for the ANS-
dTTP, two magnesium ions and 235 residues. After initial
minimization, the system temperature was increased to 400 K
and then cooled to room temperature (300 K). Subsequently,
the structure was again minimized. The ﬁnal structure repres-
ents a reﬁned starting conformation of the ANS-dTTP com-
plex, useful for initial analyses and as a starting point for
further detailed modeling studies. For comparison purposes,
the same approach was applied to the dTTP X-ray structure
with the RT and DNA structures.
The reﬁned dTTP structure after simulated annealing and
minimization is shown in Figure 5A. The overall shape of the
pyrimidine ring is slightly distorted from that in the X-ray
structure (Figure 4A); the gamma-phosphate group moved
away from the side chain N-atom of K70. However, the
Table 1. In vitro forward mu tation assay error results for HIV-RT utilizing
either natural or gamma-modified dNTP substrates
Mutational class dNTPs ANS-dNTPs
Number
of
mutants
Mutational
frequency
(· 10
 4)
Number of
mutants
Mutational
frequency
(· 10
 4)
Single-base
substitutions
178 124 26 20
Single-base
frameshifts
33 23 5 4
Multiple mutations 38 5
Mutation:
From!To
Fold
reduced
w/ANS
T_C 113 93 10 9 10
G_T 26 21 9 8 3
A_T 2 2 2 2 1
A_C 3 2 1 1 2
C_T 6 5 2 2 3
G_C 4 3 1 1 3
A_G 4 3 1 1 3
G_A 10 8 0 CD >8
T_G 3 2 0 CD >3
C_A 5 4 0 CD >4
T_A 2 2 0 CD >2
C_G 0 CD 0 CD CD
The results are the sum of two independent reactions per substrate at a con-
centration of 500 mM each. If a clone contained more than one mutation, each
mutation was counted as an individual event. ‘Multiple mutants’ indicates
the number of phage containing more than one mutation. CD: cannot be
determined.
A B
C D
Figure 4. Modeling dTTP and ANS-dTTP in the HIV-RT complex. The back-
bone structures of p66 and p51 are rendered in brown and green ribbons,
respectively.Thelighterbrownregionrepresentsresiduesfrom1to235(finger
and palm domains) which were allowed to move during the simulations. The
DNA template and primer backbone structures are rendered in red and blue
ribbons, and two Mg
2+ ions are rendered as cyan spheres. In each figure, the
following colors were used for the different atoms: C-green, O-red, N-blue, P-
pink,andS-yellow.(A)TheX-raystructureofthedTTPwasdisplayedwiththe
neighboring residues of the two Mg
2+ ions and the gamma-phosphate moiety:
K65,K70,D110,V111,D113,D185andD186.ThedTTPstructureisadjacent
to the primer DNA in ball and stick. (B) For the initial structure of ANS-dTTP,
the ANS group was manually attached to an oxygen atom of the gamma-
phosphategroup.Thetenmemberedringandsulfategroupwereplacedwithout
atomic overlaps against the existing atoms of the p66 domain of the HIV-RT
structure. Forcefield parameters were developed for the ANS linked to the
gamma-phosphate via an oxygen atom, instead of an NH group, to simplify
theforcefieldparameterizationprocess.(C)Solventaccessiblesurfacerender-
ingsforpanelAisshown.(D)SolventaccessiblesurfacerenderingsforpanelB
isshown.ViewinganglesinpanelsCandDwereslightlychangedfromthoseof
A and B to more clearly show the locations of gamma-phosphate and ANS
groups.
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well conserved. Although our simulated annealing approach
caused minor structural distortions, it did not introduce
unphysical change to the ternary complex. Of course, this
was in part by design since most of the protein (76.4%)
was held rigid. For the ANS-dTTP structure (Figure 5B),
the sugar ring and the pyrimidine ring of the ANS-dTTP
are very similar to those of the X-ray structure (Figure 4B).
Interestingly, the side chain of K70 maintains the interaction
with the termini of the substrates. The backbone geometries of
residues from 68 to 72 signiﬁcantly changed their positions to
adjust to the new interactions. The ANS group is well aligned
along the valley of the p66 domain. This result supports the
idea that the effect of adding ANS to the dTTP structure can be
compared to an extension of the phosphate chain.
Further computational experiments were performed to
model the interaction of non-complementary DNA bases
with and without the ANS moiety. A, C and G were introduced
in place of ‘T’ to investigate the effect of the ANS group in the
ﬁdelity enhancement of the DNA synthesis reaction. Based on
the reﬁned structures of the dTTP and ANS-dTTP (Figure 5A
and 5B), the remainingdNTP andANS-dNTP structures forA,
C and G were manually built by manipulating the pre-existing
pyrimidine ring using the BUILDER module of INSIGHTII.
After initial energy minimizations, the identical simulated
annealing procedures were applied to each structure to obtain
reﬁned conformations for each of the ternary complexes, and
these reﬁned conformations of mispair complexes with or
without ANS were compared with those of the complementary
base, T (Figures 5C and D).
The conformations of dNTPs without ANS (Figure 5C) are
predicted to be more similar to each other, in contrast to those
of the ANS-dNTPs (Figure 5D). In particular, the positions of
the sugar ring and the alpha phosphate, both of which are
critical positions in the DNA synthesis reaction, are more
closely aligned with each other in the models containing
unmodiﬁed dNTPs. However with the addition of the ANS
group (Figure 5D), large differences in the binding conforma-
tion between the complementary and non-complementary
bases are predicted.
DISCUSSION
Highly accurate enzymatic DNA synthesis requires that the
DNA polymerase recognizes and transmits information about
the identity of the bases within a template sequence, either
before or immediately after nucleotide incorporation. Current
models suggest that the geometry of the active site plays a role
in ﬁdelity by distinguishing the dimensions of a correct versus
and an incorrect base pair (8,12,31,32). Nucleotide analogs
containing base (33–36), sugar (37–42), or phosphate (43–46)
modiﬁcations have been designed to probe the active site
architecture. Incorporation analyses demonstrate that each
polymerase has a deﬁned tolerance for a particular nucleotide
modiﬁcation. One explanation for this variability is attributed
to the ﬂexibility within each polymerase’s nucleotide binding
pocket.
Our results show that in an M13-based forward mutation
assay HIV-RT was able to incorporate and extend all four
ANS-dNTPs. We demonstrated that HIV-RT incorporates
nucleotides with ANS attachment at the g-phosphate via a
TLC assay. Differences in the mobility of the intact ANS-
dGTP and ANS-PPi permit identiﬁcation of nucleotide incorp-
oration, which was detected by increasing intensities of
tagged-PPi with increased reaction time (Figure 2). Primer
extension analyses (data not shown) reveal that the ANS-
dNTPs are incorporated at slower rates than their natural
dNTP counterparts. Speciﬁcally, a natural dNTP typically
produces fully-extended products at approximately 10-fold
lower concentration than the ANS-dNTPs. For a misincorpor-
ated nucleotide to become a mistake, the DNA polymerase
must be able to extend the terminal mispair (48). Fewer errors
were made with the ANS-dNTP substrates than with the
dNTPs (Figure 3) for each class of mutation (Table 1). Com-
parison of the speciﬁc error types supports the trend initially
detected via primer extension reactions (data not shown):
gamma-phosphate modiﬁcations more dramatically reduce
misincorporation of purine nucleotides (Table 1). However,
misincorporation of ANS-pyrimidines (whose frequency was
already low) is also either reduced or eliminated. For example,
the G:dTTP mispair is only detected with the natural substrate.
A key feature of the wobble base pair dG:dT is its use of
alternate hydrogen bonding patterns and its ability to adopt
orientations in which either the template base or incoming
AB
CD
Figure 5. The modeled structuresof dTTP and ANS-dTTP within the HIV-RT
ternarycomplex.Thebackbonestructuresofp66andp51arerenderedinbrown
and green ribbons, respectively, and the DNA template and primer backbone
structures are rendered in red and blue ribbons. (A) The final conformation of
the modeled structure containing dTTP displayed at the same viewing angle as
in Figure 4A. (B) The final conformation of the modeled structure containing
ANS-dTTP displayed at the same viewing angle as in Figure 4B. (C) Compar-
ison of the dTTP structure with the modeled, non-complementary structures.
(D) Comparison of the ANS-dTTP structure with the modeled, non-
complementary structures. For clarity, panels C and D do not show the p66
and p51 domains or the two Mg
2+ ions. In panels C and D the dNTP and ANS-
dNTP structures for A, C, and G are colored in white, cyan, and green, respec-
tively, while the rest of the atoms are colored as in Figure 4.
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mispair is not observed, the accommodation of a shift may
not be possible in the presence of the ANS-attachment, sug-
gesting a mechanism by which the modiﬁcation improves
ﬁdelity.
HIV-RT’s low error frequency with the ANS-dNTPs resul-
ted in a reduction in the number of hotspots (29). ANS-dNTP
mutations occur at 19 positions, and 79% of these are located
at the same spots as the dNTP mutations. Primer-template
misalignments are suspected to be the underlying cause of
mutations at sites where there are runs of a common template
base (27,50,51), which is where a majority of the ANS-dNTP
errors were found. However, the largest ANS-dNTP hotspot
(+145) is not located within a run of common template bases,
but rather at the center of a palindrome.
A molecular model of the HIV-RT binding pocket with an
ANS-dTTP positioned at the primer-template was constructed.
The incorporation of a nucleotide is a dynamic process which
involves the polymerase changing its conformation from an
‘open’ to a ‘closed’ conﬁguration. Critical residues within the
ﬁngersdomainbendinwardtowardthepalmdomain andmake
contact with the incoming nucleotide, resulting in the forma-
tion of the dNTP binding pocket (30). Our model predicts that
the active site amino acid residues 68–72 sterically clashes
with the ANS-attachment at the g-phosphate. Crystal structure
analysis of a trapped catalytic complex reveals that the incom-
ing triphosphate portion of the dNTP is positioned to interact
with K65, R72 and D113 (30). The clash of the ANS-tag with
these amino acid sidechains may play a role in nucleotide
discrimination by minimizing alternative nucleotide orienta-
tions that are required for incorporation of a mismatched
nucleotide. This hypothesis is supported by the host of multi-
nucleoside resistance mutants which have been identiﬁed
within this region of the ﬁngers domain (52).
ANS attachment to the g-phosphate of a dNTP enhances
HIV-RT’s discrimination between correct and incorrect
nucleotides and demonstrates that base discrimination can
be modulated by ‘non-informational’ portions of the nucleot-
ide. A number of alternative base pairing arrangements are
proposed for mispairing events, and each requires an altered
base alignment. Molecular modeling suggests that ANS
attachment to the g-phosphate may sterically inhibit mispair
formation such that a mispair may not easily adopt an orienta-
tion that is conducive to nucleotide incorporation. Lack of
contact between the phosphates and any of the elements neces-
sary for catalysis (e.g. critical amino acid side chains, divalent
cations, or the 30-OH of the terminal base) could impair the
chemical step of the reaction.
Our data demonstrate that g-modiﬁed dNTPs improve the
accuracy at which nucleotides are inserted into a DNA strand
and our molecular modeling studies predict signiﬁcant differ-
ences in the positions of the sugar ring and the alpha phosphate
group in non-complementary base pairings involving g-
modiﬁed dNTPs. Together these results suggest that the
g-phosphate modiﬁcation may act as a signal ampliﬁer of
base identity. The conformation of the ANS group is sensitive
to the internal environment (presence of a mispair), and this
conformational information is transmitted along the attached
phosphate groups to the sugar ring position. This effect may be
the key reason for the ﬁdelity increase in the DNA synthesis
reaction.
These ﬁndings may have both therapeutic and biotechno-
logy applications. Probing the active site with nucleotide
attachments that differ in size, charge, or length of linker
will provide valuable information about the polymerase’s
ﬁdelity and potentially lead to the development of more
potent antiviral therapies. Biotechnological applications for
nucleotides modiﬁed at the gamma-phosphate may include
increased ﬁdelity of in vitro DNA replication, such as more
accurate production of ﬁrst strand cDNA, and as new sub-
strates for next generation sequencing methods.
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